Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
They published their findings recently in the Journal of Virology.
Researchers from UGA and Sanofi Pasteur, which has a research and development collaboration agreement with UGA, will present their data tomorrow, March 30, at the World Vaccine Congress US 2016 in Washington, D.C.
“One of the problems with current influenza vaccines is that we have to make predictions about which virus strains will be most prevalent every year and build our vaccines around those predictions,” said Ted Ross, director of UGA’s Center for Vaccines and Immunology and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine. “What we have developed is a vaccine that protects against multiple different strains of H1N1 virus at once, so we might be able to one day replace the current standard of care with this more broadly cross-protective vaccine.”
The H1N1 influenza virus caused a worldwide pandemic in 2009. When it was first detected, it was called swine flu because the virus was similar to those found in pigs, but the virus now circulates as a seasonal form of influenza.
Using a technique called Computationally Optimized Broadly Reactive Antigen, or COBRA, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley, along with Ross, created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.
The COBRA vaccines were designed to recognize H1N1 viruses isolated within the last 100 years, but many of the experimental vaccines produced immunity against influenza strains not included in the design. This means that scientists may be able to produce a vaccine that not only protects against recognized seasonal and pandemic influenza strains, but also strains that have yet to be discovered.
Because this vaccine is generated from the genetic sequences of multiple flu viruses, it may protect against many strains over several years, Ross said. That would also allow for year-round manufacturing of the vaccine, since scientists would not have to halt production every year to identify the most prevalent strains.
This research is part of a broader effort to create a universal influenza vaccine, which would protect against all strains of the virus.
“We still have some work to do before we get a truly universal flu vaccine,” Ross said. “But the COBRA vaccine we’ve developed for H1N1 virus subtypes is a major step in the right direction.”
Learn more: UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza
The Latest on: Flu vaccine
[google_news title=”” keyword=”flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Flu vaccine
- Pathologists’ Influenza Warning To Kiwis – “Flu Season Is Already Here”on May 7, 2024 at 5:07 pm
Pathologists are warning kiwis that flu season has arrived early this year, and now is the time to get vaccinated, to be aware of symptoms, and to stay home if influenza is suspected. Influenza (flu) ...
- Experts provide facts about avian influenza for dairy producerson May 7, 2024 at 10:05 am
While a strain of highly pathogenic avian influenza virus has been detected in dairy cattle in nine states—not including New York state—the commercial milk supply continues to be safe, according to a ...
- Cold and Flu Newson May 6, 2024 at 4:59 pm
Mar. 26, 2024 — Simply asking patients to get the flu vaccine, and combining it with helpful video and print messages, is enough to persuade many who visit emergency departments to roll up their ...
- Bird Flu: U.S. Could Produce and Ship 100 Million Vaccine Doses Within Monthson May 6, 2024 at 4:59 pm
But the strain of influenza has the potential to mutate, so federal health officials are already thinking ahead toward a potential vaccine. The country has two candidate vaccine viruses available to ...
- Children born during COVID pandemic urged to get flu vaccineon May 6, 2024 at 1:04 pm
Parents of children born during the COVID-19 pandemic are being urged to get their children flu shots, with almost 5,000 cases in children aged zero to four so far this year.
- Could Avian Influenza Be The Next Covid-19?on May 6, 2024 at 11:08 am
H5N1 has been detected in over 9,000 wild birds, 90 million poultry and in dairy cattle. A recent human case in Texas has some asking if this could be the next pandemic.
- Diet and metabolic health may influence flu vaccine effectivenesson May 6, 2024 at 7:54 am
A study conducted in obese mice found that dietary interventions resulting in weight loss led to better metabolic biomarkers and improved flu vaccine effectiveness. The results highlight the potential ...
- A Novel Broad-Spectrum Antiviral with Activity Against Influenza Aon May 6, 2024 at 2:40 am
NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says NanoViricides ...
- New influenza vaccine strategies aim to enhance protection with T-cell responseson May 5, 2024 at 11:13 pm
A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.
- 'Vaccine fatigue' blamed for drop in NHS staff uptake of flu jabon May 4, 2024 at 11:16 pm
Vaccine "fatigue" has been blamed for a drop in flu jab uptake among NHS workers at a Nottinghamshire trust. Fewer than three in five workers at Sherwood Forest Hospitals NHS Foundation Trust got the ...
via Bing News